Advancing Therapies for Patients

Find a clinical trial

page image

About Us

shadow image

Text Size

minus image

plus image

plus image

Print

Print image

Email a Friend

Our Team

Anita Sexton, PhD, MBA

Anita Sexton, PhD, MBA

Head of Sarah Cannon Research Institute-UK Drug Development Unit

Dr. Sexton joined Sarah Cannon in 2019, and is responsible for the strategic and operational leadership of the Drug Development Unit (DDU) facility, business and staff in the UK. In her role, she oversees the day-to-day operational management of the Sarah Cannon Research Institute-UK DDU, contributes to the Sarah Cannon international strategy for cancer research and works to develop an oncology clinical trial menu that serves patients across the UK.

Previously, Dr. Sexton served as principle consultant for d-wise Technologies Inc. in Manchester, UK. She received her B.S. in cell and molecular biology from Essex University in 1990, a PhD in neuroscience from the University College London in 1995 and an MBA from Kingston Business School in 2004."

hero1 image
Back to Team image

Latest Videos

watch the latest videos.

Learn more

News

news from the industry.

Read more

hero1 image
Sarah Cannon Research UK NHS Ventures
University College London Hospitals
LOC